stockmarketproxy
/
DXCMNasdaq SEC EDGAR

DEXCOM INC

Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA·FY end 12/31·CIK 1093557
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$4.7B$4.0B$3.6B$2.9B$2.4B
Gross Profit$2.8B$2.4B$2.3B$1.9B$1.7B
Operating Income$911.8M$600.0M$597.7M$391.2M$265.8M
Net Income$836.3M$576.2M$541.5M$341.2M$154.7M
Operating CF$1.4B$989.5M$748.5M$669.5M$442.5M
Capex$363.5M$358.8M$236.6M$364.8M$389.2M
Free Cash Flow$1.1B$630.7M$511.9M$304.7M$53.3M
Buybacks$500.0M$750.0M$188.7M$557.7M—
Dividends——————
Gross Margin60.1%60.5%63.2%64.7%68.6%
Operating Margin19.6%14.9%16.5%13.4%10.9%
Net Margin17.9%14.3%14.9%11.7%6.3%
FCF Margin23.1%15.6%14.1%10.5%2.2%
R&D / Revenue12.9%13.7%14.0%16.6%21.1%
Effective Tax23.2%18.7%23.8%12.7%11.0%
Debt / Equity——————
Buybacks / FCF46.4%118.9%36.9%183.0%—

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
DXCM
278:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
DXCM
$8M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
DXCM
17.9%
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%